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Mouse embryoConnexin40 (Cx40) is the main connexin expressed in the murine atria and ventricular conduction
system. We assess here the developmental role of Cx40 in atrial conduction of the mouse. Cx40 deﬁ-
ciency signiﬁcantly prolonged activation times in embryonic day 10.5, 12.5 and 14.5 atria during
spontaneous activation; the severity decreased with increasing age. In a majority of Cx40 deﬁcient
mice the impulse originated from an ectopic focus in the right atrial appendage; in such a case
the activation time was even longer due to prolonged activation. Cx40 has thus an important phys-
iological role in the developing atria.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction The role of Cx40 in human arrhythmias was studied extensivelyIntercellular connections in the heart via gap junctions play an
important role in impulse propagation in the myocardium. Cardiac
gap junctions are composed of proteins called connexins (Cxs) that
form low resistance channels, which enable electrical coupling of
adjacent myocytes allowing intercellular electrical communica-
tion. Many studies have shown that alterations in the localization
and expression of connexin proteins in the heart may cause abnor-
mal activation spreading through the myocardium, thus leading to
arrhythmias [1–3].
In mammalian hearts, mRNA for connexins 30.2, 40, 43 and 45
has been detected [4]. The expression of these connexins is
dynamic in different parts of the heart, and the expression pattern
is well conserved among species [5]. Each connexin forms a
channel with unique electrophysiological properties [6]. The main
connexin in murine atria is Cx40, but Cx43 and Cx45 are also
expressed in smaller amounts [7]. Nevertheless, as a differentiation
marker of the chamber myocardium [8], Cx40 is absent in the
sinoatrial node.[9,10]. The most common supraventricular arrhythmia in humans
is atrial ﬁbrillation. The studies investigating the relation between
this arrhythmia and Cx40 have yielded rather conﬂicting results
[11]. Simon et al. studied cardiac conduction abnormalities in mice
lacking Cx40 and found no case of atrial ﬁbrillation [3]. Verheule
et al. described predisposition to tachyarrhythmias in adult Cx40
deﬁcient mice after atrial burst pacing [12]. Recent studies in
humans have discovered a polymorphism in the Cx40 gene that
is connected with a higher risk of developing atrial ﬁbrillation
[13]. Recently, Yang et al. [14] described a null mutation of Cx40
signiﬁcantly associated with atrial ﬁbrillation onset in humans.
Despite this fact, most of the studies performed in Cx40 deﬁ-
cient mice were focused on the ventricular conduction system,
where several conduction pathologies such as right bundle branch
block or slowed atrioventricular conduction were described
[12,15]. In the adult mouse atria, prolongation of P wave and ecto-
pic foci were reported [16]. Probably the most comprehensive
study of the role of Cx40 deﬁciency on the developing atria was
made by Greg Morley’s group [17]. These authors described con-
duction velocity heterogeneity of the paced beat between the left
and right atria in adult mice, which is lost in Cx40 deﬁciency. At
the prenatal stages – embryonic day (ED)13.5 and ED15.5 – they
found impaired SAN impulse initiation with ectopic sites of
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Cx40 in impulse generation and spontaneous propagation in mur-
ine atria during early embryonic development.Fig. 1. Morphology of an ED12.5 mouse heart. The heart of a Cx40+/ mouse
embryo at ED12.5 in confocal projections (GFP ﬂuorescence) in three complemen-
tary views. In the anterior view, it is evident how the outﬂow tract covers the
central portion of the atria. In the posterior view, the same area is hidden by the
veins entering the right atrium. In the superior view the extensive antero-posterior
dimension of the atria is clearly visible, and a ﬁne network of pectinate muscles in
both atria can be appreciated. RA – right atrium; LA – left atrium; RV – right
ventricle; LV – left ventricle; Ao – aorta; Pu – pulmonary trunk; asterisks mark the
putative site of the SAN, distinguished from the surrounding GFP-positive atrial
myocardium by its darkness.2. Methods
2.1. Animals
Cx40:GFP knock-in mice developed by Lucile Miquerol [18] were
used. As the knock-in of the GFP disrupts the endogenous Cx40
gene, the homozygotes are functional nulls. Cx40 null mice were
maintained in homozygous state, as these animals are viable and
fertile (albeit with a reduced life span, a smaller number of em-
bryos per litter and a non-Mendelian ratio of nulls in heterozygous
matings). Heterozygous embryos were obtained from timed mat-
ings of a Cx40-deﬁcient male and a wild type (WT) female; for
WT, mixed genetic background related to the Swiss strain and
Cx40:GFP mice was used [19]. The experimental protocol was ap-
proved by the local animal committee and conforms to the Guiding
Principles in the Care and Use of Vertebrate Animals in Research
and Training.
2.2. Optical mapping of embryonic hearts
The animals were caged together overnight, and the noon of the
day of vaginal plug detection was considered ED0.5. Pregnant fe-
males were killed by cervical dislocation on ED10.5, 12.5 and
14.5 and the embryos were rapidly dissected in ice-cold (to pre-
vent ischemic damage to the heart) Tyrodes solution (composition:
NaCl 145 mmol/l, KCl 5.9 mmol/l, CaCl2 1.1 mmol/l, MgCl2
1.2 mmol/l, glucose 11 mmol/l, HEPES 5 mmol/l; pH = 7.4). These
stages were selected to cover the early period of cardiac develop-
ment prior to septation. The hearts with adjacent posterior body
wall structures were isolated and stained in 2.5 mmol/l di-4-ANE-
PPS (Invitrogen) for 10 min. Motion control was achieved by addi-
tion of 0.1 lM blebbistatin (Sigma) and pinning the torso to the
bottom of the dish. Because of different focal planes for atria and
ventricles (Fig. 1), our standard imaging protocol had to be modi-
ﬁed slightly as we were unable to use the recordings performed
for the analysis of ventricular activation patterns in a separate
study [19]. To avoid any perturbation of the pacemaking region,
we chose the antero-superior view (Figs. 1 and 2). Despite the
overall transparency of the heart, the outﬂow region obscured
the central area, where the pacemaker is normally located; for this
reason, we removed the outﬂow tract at the ventricular border and
at its distal connection to pharyngeal arch arteries. Data acquisi-
tion and analysis were performed using the Ultima L high-speed
camera and bundled software as described recently [20]. To better
appreciate the dynamics of atrial activation, the percentile activa-
tion over time method, recently validated by the Gourdie lab [21],
was used (Fig. 2). The area of each color band was measured and
expressed as a percentage of the whole atrial area. We then inter-
polated the data in the resulting graph to obtain times, at which
20%, 40%, 60%, 80%, and 100% of the atria was activated. Times
across these intervals were then averaged among groups. Differ-
ences in quantitative parameters among groups were analyzed
by ANOVA and Scheffe’ test for multiple comparisons. Values be-
tween left and right atriumwere compared using paired two-tailed
Student’s t-test. In all cases, values of P < 0.05 were considered sta-
tistically signiﬁcant.
2.3. Immunohistochemistry
To obtain a morphological view of the atrial myocardium and
SAN position, six WT embryos and ten embryos of the Cx40/ lineat ED12.5 were ﬁxed in 4% paraformaldehyde in PBS overnight at
4 C, and transferred into OCT medium through ascending saccha-
rose gradients. Ten-micron sections were cut on a cryomicrotome,
Fig. 2. Activation patterns of the atria at ED12.5 in WT, Cx40+/ and Cx40/
hearts. In Cx40/ hearts there are two main patterns of activation – normal SAN
activation (third row) and ectopic activation (fourth row). In the ﬁrst column are
shown microscopical images of hearts with removed outﬂow tract (conotruncus –
CT – labeled in the ﬁrst image). In the second column are the corresponding
activation maps. LA – left atrium; LV – left ventricle; RA – right atrium; RV – right
ventricle; asterisk – site of ﬁrst breakthrough (activation site). The chart below
shows quantiﬁcation of atrial activation times and dynamics. The time course of
atrial activation demonstrates a signiﬁcant delay between the left and right atrium
in the right atrial ectopic activation.
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and alternatively stained with hematoxylin-eosin, anti-HCN4
(1:500, Alomone labs), and anti-Cx43/wheat germ agglutinin/Hoe-
chst (Sigma/Invitrogen). The speciﬁc antibody binding was visual-
ized with goat-anti-rabbit antibody (Jackson Immuno) coupled
with peroxidase with diaminobenzidine as a color substrate and
hematoxylin nuclear counterstain, or by ﬂuorescently labeled sec-
ondary antibody. Images were acquired on an upright Olympus
BX51 microscope equipped with an Olympus DP71 CCD camera,and assembled and labeled in Adobe Photoshop. Confocal series of
anti-Cx43 labeling were collected on an Olympus confocal micro-
scope using 40 oil immersion lens, and quantiﬁed using ImageJ
as described [22]. Brieﬂy, the signal from the red channel (Cx43 sig-
nal) was thresholded, and the resulting area of punctate immunop-
ositivitywasmeasured in pixels. Sameprocedurewas performed for
the autoﬂuorescence channel, with the resulting tissue area used as
100%. Ratio of Cx43-positive area to total tissue areawas then calcu-
lated, and expressed as percentage.
3. Results
The activation of the ED10.5 atria originated in an area right
from the midline where the SA node is localized [23], and took
on average 6 (n = 8) ms (Fig. 3). Same activation pattern, but almost
doubled activation time, was observed in the heterozygotes
(n = 17). The homozygotes showed a wide range (11–92, n = 13)
of activation times, some within the range of the heterozygotes,
but some extremely long close to 100 ms.
In ED12.5 mouse embryos, the atrial appendages were small
and the atria were clearly visible in frontal view (Fig. 1). We thus
analyzed the spreading and the pattern of activation in the ante-
ro-superior view, after careful removal of the outﬂow tract.
The prototypical atrial activation patterns observed in our
recordings are shown in Fig. 2. In WT mice (n = 19) the activation
pattern was quite uniform among samples. The ﬁrst epicardial
breakthrough (the site of the ﬁrst electrical activation) was located
between the right and left atrium in the roof of the right atrium at
the entrance of the superior caval vein, in the place where the sin-
oatrial node is known to be located at these embryonic stages [24–
26]; the signal then spread to both atria, with the right atrium
being activated sooner. There was a clear preference for activation
spreading along the roof ﬁrst, resulting in the atrial appendages
being activated from the top towards their junction with the ven-
tricles (Fig. 2). The average time of total atrial activation was also
evaluated (7 ms; see Fig. 3). Conduction velocity in the right atrium
was 15.6 ± 7.0 cm/s; conduction was signiﬁcantly slower in the left
atrium (11.5 ± 3.3 cm/s).
In Cx40+/mice (n = 12) we saw an identical activation pattern.
The ﬁrst breakthrough was in the SAN area, but the average time of
atrial activation was signiﬁcantly prolonged compared to controls;
it took on average 9 ms to activate both atria. Conduction velocity
was signiﬁcantly slower than in the wild type in the right atrium
(10.8 ± 3.1 cm/s) but not in the left one (10.8 ± 3.3); the gradient
between the atria was absent.
In the hearts deﬁcient of Cx40 (Cx40/) we generally saw two
patterns of activation. Only 6 of the 18 hearts analyzed at ED12.5
showed the typical pattern observed in WT hearts (i.e., activation
from the SAN area); in the remaining 12 hearts an ectopic focus
of the ﬁrst electrical activation in the right atrial appendage was
detected (Fig. 2). Moreover, we found that the total atrial activation
times differed depending on the site of activation. In the case of
activation from the SAN area, the average time of activation was
19 ms vs. 28 ms necessary for atrial activation from the ectopic
site. These differences were statistically signiﬁcant (Fig. 3). Analy-
sis of atrial activation dynamics showed graphically that the pro-
longation of total activation time was due to a delay in activation
between the right and left atrium, apparent as a change in slope
between 40% and 60% of activated atrial area (Fig. 2). Conduction
velocities were signiﬁcantly slower than both wild type and het-
erozygous animals in both right (5.1 ± 1.9 cm/s) and left
(4.4 ± 0.8), which were not, however, signiﬁcantly different from
each other (P = 0.28). The conduction velocity also did not differ
between SA-originating and ectopic beat in neither left nor right
atrium; thus, the increased total activation time could be attrib-
Fig. 3. Activation times of atria at ED10.5 to ED 14.5. The values are means ± S.D. ED10.5: ⁄statistically signiﬁcant vs. WT; ⁄⁄⁄statistically signiﬁcant vs. both WT and
heterozygotes. ED12.5: ⁄statistically signiﬁcant vs. WT; ⁄⁄statistically signiﬁcant vs. SAN activation; ⁄⁄⁄either Cx40/ group is signiﬁcantly different vs. bothWT and Cx40+/
hearts. ED14.5: ⁄signiﬁcantly different vs. both WT and Cx40+/ hearts. There is no difference between WT and Cx40+/ hearts (NS). Total activation times are based on
isochronal maps shown in Fig. 2, with numbers over 10 per group. Compared by ANOVA and Scheffe’ test for multiple comparisons.
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site (Fig. 2). The frequency of this ectopic pacemaker was regular
and it did not migrate during the individual recordings.
We also tried to analyze the hearts at ED14.5 in the same way,
but at this stage the atrial appendages protrude forward, making it
difﬁcult to get both them and the back of the atria into the same
focal plane without mechanically deforming their shape (such a
thing could affect the activation properties of the atria). Neverthe-
less, we can conclude from our data that the activation patterns re-
mained the same: in WT hearts (n = 5) the predominant pattern
was still the activation from the SAN area, and in Cx40/
(n = 11) there were the same two patterns of activation described
above. The activation times were likewise prolonged in the Cx40
deﬁcient mice (Fig. 3); there was no signiﬁcant difference between
the wild type and the heterozygotes (n = 9).
We were also interested in the frequency of spontaneous atrial
rhythm. The average rate of the WT atria at ED12.5 in vitro was
96 ± 28 bpm. When the activation originated in the SAN, the fre-
quency was similar – in Cx40+/ it was 92 ± 29 bpm, and in
Cx40/ 85 ± 25 bpm (P = NS). There was a big variation in fre-
quencies in the ectopically activated atria – the average frequency
was higher at 116 ± 53 bpm, but the difference was not statistically
signiﬁcant.
Having observed all this, we hypothesized that this focus might
have a morphological substrate (e.g., some kind of ectopic SA
node). Therefore, we examined microscopically serial sections of
the hearts of ten Cx40/ and six WT mice embryos at ED12.5
and ED14.5 stained with an anti-HCN4 antibody detecting an ion
channel responsible for autonomic electrical activity in the cells,
and found no evidence of HNC4-positive cells in the right append-
age in Cx40 mutants (Supplemental Fig. 1). HNC4 expression was
detected in the posterior wall of the right atrium as well as around
the oriﬁce of the pulmonary vein, which corresponds with the
whole mount in situ hybridization study by Garcia-Frigola et al.
[23]. Lower levels of HNC4 signal were found throughout the atria
and even lower signal, but clearly above background, was present
in the ventricles (Supplemental Fig. 1). Staining of neighboring (sis-
ter) sections with wheat germ agglutinin did not reveal any signif-
icant increase of ﬁbrosis, which was minimal in the atrial tissue
(data not shown). Scanning electron microscopy was also per-
formed to complement the morphological evaluation of the atria
(data not shown) and revealed no signiﬁcant changes in atrial mor-
phology or arrangement of the pectinate muscles.To study possible compensatory changes caused by expression
of Cx43, we performed immunohistochemical reaction on adjacent
sections from ED10.5, 12.5, and 14.5 hearts. No signal was present
at ED10.5, in agreement with previous in situ hybridization study
by Delorme and associates [7]. There was an increase in immuno-
reactivity (+96%WT, +36% Cx40/) between ED12.5 (0.46 ± 0.10%
WT, 0.29 ± 0.05 Cx40/) and 14.5 (0.90 ± 20.6% WT, 0.39 ± 0.15
Cx40/). with increased localization of the particles to the cell
membrane (Supplemental Fig. 2). There was a trend towards lower
Cx43 levels in the Cx40/ atria (37%, P = 0.047 at ED12.5 and
57%, P = 0.097 at ED14.5).4. Discussion
The role of Cx40 in cardiac arrhythmogenesis has been de-
scribed earlier by a number of research groups [9,10,13]. Despite
this, the functional role of this protein in development is still not
fully understood. Our study contributes to this understanding with
the following conclusions: (1) The lack of Cx40 in the embryonic
atria directly inﬂuences the conduction properties of atrial myo-
cardium (see Fig. 3). This is consistent with the fact that Cx40 is
the main gap junction protein in murine atria [6]. The function of
missing Cx40 could be substituted by other connexins, especially
Cx43. According to the study by Delorme et al., the expression of
Cx43 in mouse atria is detectable by in situ hybridization from
ED12.5 onwards [7]. In our data, the prolongation of activation
times in Cx40 deﬁcient atria compared to WT is much higher at
ED10.5 or 12.5 (more than 3 times longer) in contrast to ED14.5
(only about 30% more, see Fig. 3), suggesting a mechanism of
developmental compensation from the 43 isoform. Lower levels
of Cx43 observed in Cx40/ are not likely biologically signiﬁcant,
as the amounts must be decreased by more than 90% to observe
physiological phenotype. (2) In 2/3 of Cx40/ embryonic hearts
at ED12.5, the ﬁrst breakthrough was located in an ectopic site in
the right atrium without the presence of any morphological or
molecular substrate that could explain these autorhythmic proper-
ties; this might reﬂect an abnormal exit [27] of the impulse from
the SAN. However, study performed in the adult Cx40/ mice
indicated that there are truly ectopic foci, since their ablation
resulted in re-location of the pacemaker back to the SA node,
although with much reduced frequency [16]. Accordingly, we did
not ﬁnd any morphological changes in SA node formation in
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pacing from ectopic foci was rather irregular, suggesting also a
functional problem. (3) When the excitation was spreading from
this ectopic place, the activation time of both atria was even more
prolonged than in the rest of the CX40/. We hypothesize that
this could be a consequence of the presence of a preferential path-
way (Bachmann’s bundle) of signal spreading from the SAN to the
left atrium, as described in the chick embryos [28] as well as other
species [29] including humans [30]. This preferential pathway does
not seem to be fully utilized during the ectopic activation (Fig. 2),
resulting in prolonged conduction through the working right atrial
myocardium with the interatrial septum causing a further delay by
acting like a sink. However, the conduction velocity did not differ
signiﬁcantly between the SA-originating and ectopic activation in
neither left nor right atrium of the CX40/ deﬁcient hearts; thus,
the increased activation time could be attributed to the prolonged
pathway the impulse had to travel from the ectopic site.
Verheule et al. described several cardiac conduction abnormal-
ities in adult mice lacking Cx40 [12]. They found a P wave prolon-
gation on surface electrocardiographs (corresponding to the atrial
activation time) and a 30% decrease in the conduction velocity in
Cx40/ mice compared with the WT. In addition, burst pacing
was able to provoke atrial tachyarrhythmias in 50% of the mutants.
This prolongation of atrial activation time is quantitatively very
similar to our results at ED14.5, and such slowing of conduction
velocity could be one of the arrhythmogenic factors in human
cases of Cx40 disruption.
This is the ﬁrst study that maps in detail the effect of CX40 deﬁ-
ciency on activation spreading and times of murine embryonic at-
ria at and before ED12.5. Leaf et al. performed an extensive study
about the effect of Cx40 on conduction heterogeneity in adult mice
of a wide range of ages as well as in embryos (ED13.5 and ED15.5)
[17]. These authors also showed the amount of Cx40 protein is re-
duced by approximately 50% in the Cx40+/ atria. In their study
they detected the presence of more ectopic sites of activation at
ED15.5, localized also in the left atrium, whereas at ED13.5 they
described normal SA node activation both in Cx40+/+ and in
Cx40/ mice. This is in contrast with our data, as we found ecto-
pic activation already at ED12.5 in two thirds of the hearts. Such a
discrepancy can be due to a different method of gene deletion (un-
like Leaf et. al. we used GFP:Cx40 knock-in mouse line), and/or to
the inﬂuence of different genetic background of the strains, and/or
to slightly different methodological approaches (we did not use
signal averaging and motion tracking in our optical recordings).
Interestingly, we were unable to correlate the ectopic pacemaker
with any morphological substrate, either ﬁbrosis with myoﬁbrillar
disarray, or abnormal pacemaking channel expression domain.
In conclusion, this study shows that a lack of Cx40 in atria dur-
ing development inﬂuences the activation patterns of spontaneous
impulse propagation and signiﬁcantly slows impulse propagation
velocity (which directly correlates with the type of atrial activa-
tion). The most signiﬁcant effect is observed at the earliest stages,
where the expression of Cx43 does not compensate for the deﬁ-
ciency of Cx40. This study improves our understanding about the
electrophysiological function of Cx40 during embryonic develop-
ment and the relationship between the activation times of atria,
the amount of Cx40 and the site of activation.
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